TP53 and cancer: Consequently, if successful, molecular imaging offers the advantage of non-invasively visualizing and quantifying mutant p53 in cancer patients, allowing for early detection and precise characterization of cancerous lesions, guiding treatment decisions, and monitoring treatment response.